$62.65
Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?
10x Genomics Needs "Meaningful' Growth in Single-Cell Business, RBC Says
RBC Initiates 10x Genomics at Sector Perform With $70 Price Target
Overview
52-week range
$11
$67
92% of range
Avg surprise (last 3)
+88.5%
Avg reaction (last 2)
+1.2%
50% positive
Latest IV / EM
69%
EM ±10.8% · $65 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.14 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-0.10 | $-0.29 | +65.5% | +72.2% | -1.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.22 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.28 | $-0.35 | +180.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.36 | $-0.45 | +20.0% | — | +3.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.30 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.32 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.50 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.79 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.53 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.44 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $151M | $151M | — | $149M | $173M | $155M | — | $152M |
| Cost of revenue | $39M | $45M | — | $49M | $48M | $49M | — | $45M |
| Gross profit | $112M | $106M | — | $100M | $125M | $105M | — | $106M |
| Operating income | $-20M | $-17M | — | $-32M | $30M | $-39M | — | $-41M |
| Net income | $-18M | $-13M | — | $-27M | $35M | $-34M | — | $-36M |
| EPS (diluted) | $-0.14 | $-0.10 | — | $-0.22 | $0.28 | $-0.28 | — | $-0.30 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $53M | $53M | $56M | $62M | $69M | $75M | $83M | $94M |
| Total current assets | $675M | $670M | $684M | $660M | $656M | $580M | $584M | $594M |
| Total assets | $1.03B | $1.02B | $1.04B | $1.03B | $980M | $903M | $919M | $938M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $205M | $201M | $245M | $242M | $207M | $196M | $209M | $215M |
| Total equity | $826M | $814M | $796M | $785M | $773M | $707M | $710M | $723M |